Invesco NASDAQ Future Gen 200 ETF (QQQS)
| Assets | $7.15M |
| Expense Ratio | 0.20% |
| PE Ratio | n/a |
| Shares Out | 300,000 |
| Dividend (ttm) | $0.17 |
| Dividend Yield | 0.69% |
| Ex-Dividend Date | Mar 18, 2024 |
| Payout Ratio | n/a |
| 1-Year Return | -12.00% |
| Volume | 444 |
| Open | 24.50 |
| Previous Close | 24.06 |
| Day's Range | 24.49 - 24.50 |
| 52-Week Low | 19.91 |
| 52-Week High | 30.41 |
| Beta | 1.41 |
| Holdings | 207 |
| Inception Date | Oct 13, 2022 |
About QQQS
Fund Home PageThe Invesco NASDAQ Future Gen 200 ETF (QQQS) is an exchange-traded fund that is based on the Nasdaq Innovators Completion Cap index. The fund tracks an equal-weighted index of 200 NASDAQ-listed stocks selected based on the value of their patent portfolios. The portfolio excludes the largest 200 stocks listed on NASDAQ. QQQS was launched on Oct 13, 2022 and is issued by Invesco.
Top 10 Holdings
8.51% of assets| Name | Symbol | Weight |
|---|---|---|
| Geron Corporation | GERN | 1.06% |
| Alpine Immune Sciences, Inc. | ALPN | 1.05% |
| SIGA Technologies, Inc. | SIGA | 0.98% |
| Semtech Corporation | SMTC | 0.86% |
| CorMedix Inc. | CRMD | 0.85% |
| X4 Pharmaceuticals, Inc. | XFOR | 0.79% |
| Avadel Pharmaceuticals plc | AVDL | 0.77% |
| Turtle Beach Corporation | HEAR | 0.77% |
| OPKO Health, Inc. | OPK | 0.70% |
| Tandem Diabetes Care, Inc. | TNDM | 0.68% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 18, 2024 | $0.06716 | Mar 22, 2024 |
| Dec 18, 2023 | $0.03706 | Dec 22, 2023 |
| Sep 18, 2023 | $0.02839 | Sep 22, 2023 |
| Jun 20, 2023 | $0.03563 | Jun 23, 2023 |
| Mar 20, 2023 | $0.07699 | Mar 24, 2023 |
| Dec 19, 2022 | $0.01075 | Dec 23, 2022 |
News
Biotech Rebound Could Boost This ETF
Biotech stocks and the related exchange traded fund are in the midst of a lengthy run of disappointing investors. With the NASDAQ Biotechnology Index lower on a year-to-date basis, some market partici...
What It Will Take for Small-Caps to Rebound
Is a rebound on the way? The Russell 2000 Index, one of the most widely followed gauges of small-cap stocks, is higher by 2.82% year-to-date, but that's still well above the pace set by the S&P 500, w...
Small-Cap Opportunity Set Still Looks Attractive
Small-caps lagged last year. That's because a small number of mega-cap growth stocks accounted for the bulk of the broader market's returns.
The Case for Small Caps Is Getting Interesting
Broader gauges of small caps didn't do much to brag about through the first two months of 2024. However, some market observers believe the asset class is poised for a turnaround.
Invesco takes the regulatory steps to expand its ETF business in Japan
ATLANTA , June 20, 2023 /PRNewswire/ -- Invesco Capital Management LLC, an investment adviser managing an extensive family of exchange-traded funds (ETFs), announced today that our global ETF business...
Invesco Adds ‘Future Gen' to QQQ Suite
Technology-focused ETF tracking innovator index began trading Thursday.
Invesco Expands QQQ Innovation Suite to Include Small-Cap ETF
Invesco NASDAQ Future Gen 200 ETF (QQQS) will screen smaller-cap companies by estimated patent value to select 200 Nasdaq-listed companies for investmentNDAQ ATLANTA , Oct. 13, 2022 /PRNewswire/ -- In...